BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16882664)

  • 1. Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein.
    Oh W; Yang MR; Lee EW; Park KM; Pyo S; Yang JS; Lee HW; Song J
    J Biol Chem; 2006 Oct; 281(40):30166-74. PubMed ID: 16882664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp70 functions as a negative regulator of West Nile virus capsid protein through direct interaction.
    Oh WK; Song J
    Biochem Biophys Res Commun; 2006 Sep; 347(4):994-1000. PubMed ID: 16854374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
    Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
    J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MKRN1 induces degradation of West Nile virus capsid protein by functioning as an E3 ligase.
    Ko A; Lee EW; Yeh JY; Yang MR; Oh W; Moon JS; Song J
    J Virol; 2010 Jan; 84(1):426-36. PubMed ID: 19846531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jab1 as a mediator of nuclear export and cytoplasmic degradation of p53.
    Lee EW; Oh W; Song J
    Mol Cells; 2006 Oct; 22(2):133-40. PubMed ID: 17085963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2.
    Oh W; Lee EW; Sung YH; Yang MR; Ghim J; Lee HW; Song J
    J Biol Chem; 2006 Jun; 281(25):17457-17465. PubMed ID: 16624822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus.
    Yang MR; Lee SR; Oh W; Lee EW; Yeh JY; Nah JJ; Joo YS; Shin J; Lee HW; Pyo S; Song J
    Cell Microbiol; 2008 Jan; 10(1):165-76. PubMed ID: 17697133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jab1, a novel protease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activator protein-1.
    Luo W; Wang Y; Hanck T; Stricker R; Reiser G
    J Biol Chem; 2006 Mar; 281(12):7927-36. PubMed ID: 16410250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the stress protein p8 with Jab1 is required for Jab1-dependent p27 nuclear-to-cytoplasm translocation.
    Malicet C; Hoffmeister A; Moreno S; Closa D; Dagorn JC; Vasseur S; Iovanna JL
    Biochem Biophys Res Commun; 2006 Jan; 339(1):284-9. PubMed ID: 16300740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAB1/CSN5 inhibits the activity of Luman/CREB3 by promoting its degradation.
    DenBoer LM; Iyer A; McCluggage AR; Li Y; Martyn AC; Lu R
    Biochim Biophys Acta; 2013 Sep; 1829(9):921-9. PubMed ID: 23583719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53.
    Lee EW; Oh W; Song HP; Kim WK
    BMB Rep; 2017 Jul; 50(7):373-378. PubMed ID: 28539160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas.
    Wang Y; Fei M; Cheng C; Zhang D; Lu J; He S; Zhao Y; Wang Y; Shen A
    Cancer Biol Ther; 2008 Mar; 7(3):460-7. PubMed ID: 18285702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex.
    Huang J; Yuan H; Lu C; Liu X; Cao X; Wan M
    J Mol Biol; 2007 Aug; 371(2):514-27. PubMed ID: 17583730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jab1 has negative effects on p53-mediated genotoxic stresses.
    Lee EW; Lee S; Song J
    BMB Rep; 2009 May; 42(5):299-303. PubMed ID: 19470245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jab1-siRNA Induces Cell Growth Inhibition and Cell Cycle Arrest in Gall Bladder Cancer Cells via Targeting Jab1 Signalosome.
    Pandey P; Siddiqui MH; Behari A; Kapoor VK; Mishra K; Sayyed U; Tiwari RK; Shekh R; Bajpai P
    Anticancer Agents Med Chem; 2019; 19(16):2019-2033. PubMed ID: 31345154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A7, Jab1, and p27
    Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F
    J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of the Chemopreventive Role of Stigmasterol Against Jab1 in Gall Bladder Carcinoma.
    Pandey P; Bajpai P; Siddiqui MH; Sayyed U; Tiwari R; Shekh R; Mishra K; Kapoor VK
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):826-837. PubMed ID: 30727937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
    Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
    Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific interaction of capsid protein and importin-alpha/beta influences West Nile virus production.
    Bhuvanakantham R; Chong MK; Ng ML
    Biochem Biophys Res Commun; 2009 Nov; 389(1):63-9. PubMed ID: 19712667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAB1 regulates unphosphorylated STAT3 DNA-binding activity through protein-protein interaction in human colon cancer cells.
    Nishimoto A; Kugimiya N; Hosoyama T; Enoki T; Li TS; Hamano K
    Biochem Biophys Res Commun; 2013 Aug; 438(3):513-8. PubMed ID: 23911788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.